Clinical Trials Directory

Trials / Completed

CompletedNCT00000345

Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10

Evaluation of Lofexidine for Treatment of Opiate Withdrawal

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
0 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the safety of lofexidine in the treatment of opiate-dependent individuals.

Conditions

Interventions

TypeNameDescription
DRUGLofexidine

Timeline

Start date
1996-04-01
First posted
1999-09-21
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000345. Inclusion in this directory is not an endorsement.